No Data
No Data
Earnings Preview: MediciNova to Report Financial Results Post-market on February 14
$MediciNova(MNOV.US)$ is scheduled to release its financial results post-market on February 14 ET. Earnings PreviewAnalysts estimate $MediciNova(MNOV.US)$ to post revenue of USD0 for 2024Q4, EPS is
MediciNova Presents Study Update And Interim Analysis Of Phase 2/3 Clinical Trial Of MN-166 In ALS At The 35th International Symposium On ALS/MND
Express News | MediciNova Inc - Expects to Complete Patient Assignments by June 2025 With Trial Results Expected in 2026
Express News | MediciNova Inc - Positive Correlations Observed Between 6-Month and 12-Month Data
Express News | Medicinova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of Mn-166 (Ibudilast) in ALS (Combat-ALS Clinical Trial) at the 35TH International Symposium on ALS/Mnd
Volume change rate ranking (9am) - Nishika, WealthNavi, etc. are ranked.
In the volume change rate ranking, by comparing the average volume of the past 5 days with the volume on the day of distribution, it is possible to understand the interest of market participants such as trends in transactions. Top volume change rate [as of 9:34 on December 3] (comparison with average volume of the past 5 days) Stock Code Stock Name Volume 5-day Average Volume Volume Change Rate Stock Price Change Rate <7342> WealthNavi 3479800 10718 5.08 305.83% 0.17% <2634>